Table: Fuji Pharmaceutical - 9-MTH group results

Fuji Pharma

06/08/2026 08:30

    Aug 6 (Reuters)- 
             Fuji Pharmaceutical  Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Jun 30, 2026        Jun 30, 2025     Sep 30, 2026 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             45.38               36.95            59.25    
                 (+22.8 pct)         (+11.5 pct)      (+14.7 pct) 
  Operating          5.39                3.37             6.12    
                 (+60.2 pct)         (+52.0 pct)      (+22.6 pct) 
  Recurring          5.48                3.16             5.88    
                 (+73.5 pct)         (+6.4 pct)       (+31.9 pct) 
  Net                1.82                1.83             2.24    
                 (-0.6 pct)          (-62.7 pct)      (-25.3 pct) 
  EPS             72.11 yen           75.07 yen        91.54 yen  
  Ann Div                             45.50 yen        49.00 yen  
  -Q2 div         23.00 yen           20.00 yen                   
  -Q4 div                             25.50 yen        26.00 yen  
  
  NOTE - Fuji Pharmaceutical  Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4554.T